Common side effects include nausea, diarrhea, and decreased appetite, which often subside over time
Pediatr Hematol Oncol 18 , 491495
Compared with other non-insulin hypoglycaemic agents, GLP-1RAs have the advantage of lowering HbA1c by a large margin and improving cardiovascular system and renal function without causing hypoglycaemia and weight gain (Table 2)
le fonctionnement normal du systme immunitaire
These provide essential nutrients and support satiety
An in vitro study in hCAECs found that exenatide decreased inflammation by reducing activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B), adhesion molecules intracellular adhesion molecules (ICAM) and vascular cell adhesion molecules (VCAM), but not P-selectin ( Third, GLP-1 RAs potentially affect coronary plaque characteristics